ID   NCC-SS5-C1
AC   CVCL_C1GG
DR   Wikidata; Q114312462
RX   PubMed=35655041;
CC   Part of: NCC sarcoma cell line panel.
CC   Population: Japanese.
CC   Senescence: It is possible that this cell line is not immortal and has a finite life span (personal communication of Kondo T.).
CC   Doubling time: 218 hours (PubMed=35655041).
CC   Sequence variation: Gene fusion; HGNC; 11340; SS18 + HGNC; 11335; SSX1; Name(s)=SS18-SSX1 (PubMed=35655041).
ST   Source(s): PubMed=35655041
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 11
ST   D16S539: 10,12
ST   D21S11: 30
ST   D5S818: 8,10
ST   D7S820: 10,11
ST   TH01: 6
ST   TPOX: 9,11
ST   vWA: 14,17
DI   NCIt; C3400; Synovial sarcoma
DI   ORDO; Orphanet_3273; Synovial sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   75Y
CA   Cancer cell line
DT   Created: 22-09-22; Last updated: 30-01-24; Version: 4
//
RX   PubMed=35655041; DOI=10.1007/s13577-022-00721-5;
RA   Yoshimatsu Y., Noguchi R., Sin Y., Tsuchiya R., Ono T., Akiyama T.,
RA   Sugaya J., Kojima N., Yoshida A., Kawai A., Kondo T.;
RT   "Establishment and characterization of NCC-SS5-C1: a novel
RT   patient-derived cell line of synovial sarcoma.";
RL   Hum. Cell 35:1290-1297(2022).
//